COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 555: Articles 5541-5550  | Next

Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron Waves
Doll, M. K., Waghmare, A., Heit, A., Levenson Shakoor, B., Kimball, L. E., Ozbek, N., Blazevic, R. L., Mose, L., Boonyaratanakornkit, J., Stevens-Ayers, T. L., Cornell, K., Sheppard, B. D., Hampson, E., Sharmin, F., Goodwin, B., Dan, J. M., Archie, T., O'Connor, T., Heckerman, D., Schmitz, F., Boeckh, M., Crotty, S.
10.1101/2022.11.13.22282222 — Posted: 2022-11-14
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
Ramos Benitez, M. J., Strich, J. R., Alehashemi, S., Stein, S., Rastegar, A., de Jesus, A. A., Bhuyan, F., Ramelli, S., Babyak, A., Perez-Valencia, L., Vannella, K. M., Grubbs, G., Khurana, S., Gross, R., Hadley, K., Liang, J., Mazur, S., Postnikova, E., Warner, S., Holbrook, M., Busch, L. M., Warner, B., Applefeld, W., Warner, S., Kadri, S. S., Davey, R. T., Goldbach-Mansky, R., Chertow, D. S.
10.1101/2022.11.08.22281846 — Posted: 2022-11-13
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Hackney, J. A., Shivram, H., Vander Heiden, J., Overall, C., Orozco, L., Gao, X., West, N., Qamra, A., Chang, D., Chakrabarti, A., Choy, D. F., Combes, A. J., Courau, T., Fragiadakis, G. K., Rao, A. A., Ray, A., Tsui, J., Hu, K., Kuhn, N. F., Krummel, M. F., Erle, D. J., Kangelaris, K., Sarma, A., Lyon, Z., Calfee, C. S., Woodruff, P. G., Ghale, R., Mick, E., Byrne, A., Zha, S., Langelier, C., Hendrickson, C. M., van der Wijst, M. G. P., Hartoularos, G. C., Grant, T., Bueno, R., Lee, D. S., Greenland, J. R., Sun, Y., Perez, R., Ogorodnikov, A., Ward, A., Ye, C. J., UCSF COMET Consortium, , Ramalingam, T., McBride, J. M., Cai, F., Teterina, A., Bao, M., Tsai, L., Rosas, I. O., Regev, A., Kapadia, S. B., Bauer, R. N., Rosenberger, C. M.
10.1101/2022.11.07.22282049 — Posted: 2022-11-13
SIR analytical model applied to 2020 Covid-19 data in Italy
Simeone, R.
10.1101/2022.11.09.22282122 — Posted: 2022-11-13
Learning from the past: a short term forecast method for the COVID-19 incidence curve
Morel, J.-D., Morel, J.-M., Alvarez, L.
10.1101/2022.11.05.22281904 — Posted: 2022-11-13
Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19
Klose, A. M., Kosoy, G., Miller, B. L.
10.1101/2022.11.08.22282042 — Posted: 2022-11-13
Long-term experience with rapid air filtration (6 to 15 air changes per hour) in a K-5 elementary school using HEPA and Do-It-Yourself (DIY) air purifiers during the COVID-19 pandemic
Srikrishna, D.
10.1101/2022.11.05.22281734 — Posted: 2022-11-13
Requirements to minimize airborne infections related to virus aerosol contamination at indoor cultural events
Salthammer, T., Moriske, H.-J.
10.1101/2022.11.07.22281932 — Posted: 2022-11-13
Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review and Meta-Analysis of Eight Randomised Controlled Trials
Manoharan, S., Ying, L. Y.
10.1101/2022.11.07.22282055 — Posted: 2022-11-11
Year-round RSV Transmission in the Netherlands Following the COVID-19 Pandemic - A Prospective Nationwide Observational and Modeling Study
Lowensteyn, Y., Zheng, Z., Rave, N., Bannier, M. A. G. E., Billard, M.-N., Casalegno, J.-s., Pitzer, V. E., Wildenbeest, J. G., Weinberger, D. M., Bont, L., the SPREAD study group
10.1101/2022.11.10.22282132 — Posted: 2022-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).